Jul 2026
MAP1S limits autoimmune uveitis by suppressing Th17 differentiation through dual control of the EGR2-LCN2 axis and autophagic flux.
These findings establish MAP1S as a critical node integrating acetylation signaling of EGR2 and autophagic flux to govern LCN2 homeostasis and Th17 pathogenicity, revealing a promising therapeutic target for autoimmune uveitis and potentially other Th17-mediated diseases.
Ying-Jun Cai, Li-Hui Xie, Bowen Li et al.
· Autophagy · 0 citations